2nd Edition
Respiratory
Notes
Respiratory Therapist’s Pocket Guide
Gary C. White, M.Ed., RRT, RPFT
Purchase additional copies of this book at
your health science bookstore or directly
from F. A. Davis by shopping online at
www.fadavis.com or by calling 800-323-
3555 (US) or 800-665-1148 (CAN)
A Davis’s Notes Book
√ HIPAA Compliant
√ OSHA Compliant
Waterproof and Reusable
Wipe-Free Pages
Write directly onto any page of Respiratory Notes,
2nd Edition with a ballpoint pen. Wipe old entries off
with an alcohol pad and reuse.
BASICS ASSESS PHARM PULM PROC AIR VENT NEO PEDS TOOLS
Look for our other Davis’s Notes titles available now!
Respiratory Notes: Respiratory Assess Notes: Assessment and
Therapist’s Pocket Guide Diagnostic Reasoning
ISBN-13: 978-0-8036-1467-3 ISBN-13: 978-0-8036-1749-0
ECG Notes: Interpretation and DocuNotes: Nurse’s Clinical
Management Guide Pocket Guide to Effective
ISBN-13: 978-0-8036-1347-8 Documenting and Reporting
ISBN-13: 978-0-8036-2092-6
EMS Notes: EMT & Paramedic
Field Guide MedSurg Notes: Nurse’s Clinical
ISBN-13: 978-0-8036-2038-4 Pocket Guide, 2nd edition
ISBN-13: 978-0-8036-1868-8
LabNotes: Guide to Lab &
Diagnostic Tests, 2nd edition NCLEX-RN® Notes: Core Review
ISBN-13: 978-0-8036-2138-1 & Exam Prep
ISBN-13: 978-0-8036-1570-0
Critical Care Notes: Clinical
Pocket Guide NutriNotes: Nutrition & Diet
ISBN-13: 978-0-8036-2084-1 Therapy Pocket Guide
ISBN-13: 978-0-8036-1114-6
MedNotes: Nurse’s
Pharmacology Pocket Guide, Coding Notes: Medical
3rd Edition Insurance Pocket Guide
ISBN-13: 978-0-8036-2139-8 ISBN-13: 978-0-8036-1493-2
IV Med Notes: IV Administration PsychNotes: Clinical Pocket
Pocket Guide Guide, 2nd edition
ISBN-13: 978-0-8036-1446-8 ISBN-13: 978-0-8036-1853-4
IV Therapy Notes: Nurse’s PFT Notes: Pulmonary Function
Clinical Pocket Guide Testing Pocket Guide
ISBN-13: 978-0-8036-1288-4 ISBN-13: 978-0-8036-2249-4
For a complete list of Davis’s Notes and
other titles for health care providers,
visit www.fadavis.com.
113
Obstructive Diseases 114
Restrictive Diseases 118
Neuromuscular Diseases 120
Infectious Diseases 127
Circulatory Diseases 131
Neoplastic Disease 134
Chest Trauma 135
Pediatric Diseases 138
Neonatal Diseases 140
PULM
Obstructive Diseases
Bedside
Disease Etiology Assessment Laboratory Data Treatment
Chronic Smoking Tachypnea Arterial blood gases Antibiotics for
bronchitis history Accessory (ABGs): Compensated infections
Air pollution muscle use respiratory acidosis Sympathomimetic
Chronic Increased may be hypoxemic bronchodilators
infections anteroposterior Pulmonary function Inhaled
114
Gastric reflux (A-P) diameter tests (PFTs): corticosteroids
Cough/sputum Decreased FVC, FEV1, Bronchial hygiene
PULM
production FEV1/FVC, FEF25%–75%; O2 therapy for
Diminished Increased RV, FRC, hypoxemia
breath sounds RV/TLC Smoking cessation
Hyperresonance Chest radiograph: Pulmonary
on percussion Increased rehabilitation
radiolucency,
enlarged lung fields,
flattened diaphragms,
increased retrosternal
airspace
Bedside
Disease Etiology Assessment Laboratory Data Treatment
Asthma Allergic Tachypnea ABGs: Acute (early) O2 therapy for
triggers Accessory respiratory alkalosis hypoxemia
Infections muscle use with hypoxemia IV corticosteroids (ER
Exercise or Prolonged Severe (late/status treatment)
cold air expiratory asthmaticus) Sympathomimetic
exposure phase respiratory acidosis bronchodilators
Gastric reflux Increased A-P with hypoxemia Inhaled
Air pollution diameter PFTs: Decreased FVC, corticosteroids
115
Cough/sputum FEV1, FEV1/FVC, PEFR, Bronchial hygiene
production FEF25%–75%; Increased Mechanical
PULM
Hyperresonance RV, FRC, RV/TLC ventilation for
on percussion Chest radiograph: respiratory failure
Diminished Increased retrosternal
breath sounds airspace,
and wheezing hyperinflation,
flattened diaphragms,
increased
radiolucency
Continued
Bedside
Disease Etiology Assessment Laboratory Data Treatment
Emphysema Genetic Dyspnea ABGs: Compensated O2 therapy for
(alpha-1- Accessory respiratory acidosis hypoxemia
antiprotease muscle use with hypoxemia Bronchial hygiene
deficiency) Increased A-P PFTs: Decreased FVC, Sympathomimetic
Cigarette diameter FEV1, FEV1/FVC, bronchodilators
116
smoking Cough/sputum FEF25%–75%; Increased Antibiotics for
Occupational production RV, FRC, RV/TLC pulmonary
PULM
exposure Hyperresonance Chest radiograph: infections
Air pollution on percussion Hyperinflation, Prolastin replacement
Diminished flattened diaphragms, therapy for alpha-1
breath sounds, increased deficiency
wheezing, radiolucency, Pulmonary
crackles, and increased retrosternal rehabilitation
rhonchi airspace
Bedside
Disease Etiology Assessment Laboratory Data Treatment
Cystic Genetic Dyspnea ABGs: Compensated O2 therapy for
fibrosis Accessory respiratory acidosis hypoxemia
muscle use with hypoxemia Bronchial hygiene
Increased A-P PFTs: Decreased FVC, Inhaled medications:
diameter FEV1, FEV1/FVC, • Bronchodilators
117
Digital clubbing FEF25%–75%; Increased • Corticosteroids
Cough/sputum RV, FRC, RV/TLC • Antibiotics
PULM
production Chest radiograph:
Diminished Hyperinflation,
breath sounds, flattened diaphragms,
wheezing, increased
crackles, and radiolucency,
rhonchi increased retrosternal
airspace
Restrictive Diseases
Bedside
Disease Etiology Assessment Laboratory Data Treatment
Interstitial Inhalation of Dyspnea ABGs: Increased O2 therapy for
lung inorganic dusts Digital clubbing Pa-AO2, hypoxemia hypoxemia
disease Inhalation of organic Dull percussion PFTs: Decreased Inhaled medications
118
dusts note FVC, FEV1; Normal • Sympathomimetic
Drugs Bronchial breath or increased FEV1/ bronchodilators
PULM
(nitrofurantoin, sounds, FVC, FEF25%–75%, • Corticosteroids
aspirin, bleomycin, crackles, PEF; Decreased RV,
cyclophosphamide, wheezing FRC
methotrexate, Chest radiograph:
amiodarone, Patchy infiltrates,
heroin, methadone) granulomas,
Idiopathic pleural plaques, air
bronchograms
